6-Sulfo LacNAc (Slan) as a Marker for Non-classical Monocytes

被引:36
作者
Hofer, Thomas P. [1 ]
van de Loosdrecht, Arjan A. [2 ]
Stahl-Hennig, Christiane [3 ]
Cassatella, Marco A. [4 ]
Ziegler-Heitbrock, Loems
机构
[1] Helmholtz Ctr Munich, Immunoanalyt Core Facil & RG Tissue Control Immun, Munich, Germany
[2] Vrije Univ Amsterdam, Med Ctr, Dept Hematol, Amsterdam, Netherlands
[3] Deutsch Primatenzentrum GmbH, Gottingen, Germany
[4] Univ Verona, Sect Gen Pathol, Dept Med, Verona, Italy
关键词
monocyte subsets; slan; man; monkey; inflammation; cancer; CMML; lymphoma; HUMAN DENDRITIC CELLS; CD16(+) MONOCYTES; HUMAN BLOOD; MONOCLONAL-ANTIBODIES; RHEUMATOID-ARTHRITIS; EX-VIVO; SUBSET; EXPRESSION; PSGL-1; TISSUE;
D O I
10.3389/fimmu.2019.02052
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Monocytes are subdivided into three subsets, which have different phenotypic and functional characteristics and different roles in inflammation and malignancy. When in man CD14 and CD16 monoclonal antibodies are used to define these subsets, then the distinction of non-classical CD14low and intermediate CD14high monocytes requires setting a gate in what is a gradually changing level of CD14 expression. In the search for an additional marker to better dissect the two subsets we have explored the marker 6-sulfo LacNAc (slan). Sian is a carbohydrate residue originally described to be expressed on the cell surface of a type of dendritic cell in human blood. We elaborate herein that the features of slan+ cells are congruent with the features of CD16+ non-classical monocytes and that slan is a candidate marker for definition of non-classical monocytes. The use of this marker may help in studying the role of non-classical monocytes in health and in diagnosis and monitoring of disease.
引用
收藏
页数:10
相关论文
共 87 条
[1]   Fractalkine preferentially mediates arrest and migration of CD16+ monocytes [J].
Ancuta, P ;
Rao, R ;
Moses, A ;
Mehle, A ;
Shaw, SK ;
Luscinskas, FW ;
Gabuzda, D .
JOURNAL OF EXPERIMENTAL MEDICINE, 2003, 197 (12) :1701-1707
[2]   The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia [J].
Arber, Daniel A. ;
Orazi, Attilio ;
Hasserjian, Robert ;
Thiele, Jurgen ;
Borowitz, Michael J. ;
Le Beau, Michelle M. ;
Bloomfield, Clara D. ;
Cazzola, Mario ;
Vardiman, James W. .
BLOOD, 2016, 127 (20) :2391-2405
[3]   Lenalidomide in the treatment of multiple myeloma: a review [J].
Armoiry, X. ;
Aulagner, G. ;
Facon, T. .
JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2008, 33 (03) :219-226
[4]   Phenotype, Function, and Mobilization of 6-Sulfo LacNAc-Expressing Monocytes in Atopic Dermatitis [J].
Baran, Wojciech ;
Oehrl, Stephanie ;
Ahmad, Fareed ;
Doebel, Thomas ;
Alt, Christina ;
Buske-Kirschbaum, Angelika ;
Schmitz, Marc ;
Schaekel, Knut .
FRONTIERS IN IMMUNOLOGY, 2018, 9
[5]   G-CSF mobilizes slanDCs (6-sulfo LacNAc+ dendritic cells) with a high proinflammatory capacity [J].
Baumeister, Susanne H. C. ;
Hoelig, Kristina ;
Bornhaeuser, Martin ;
Meurer, Michael ;
Rieber, E. Peter ;
Schaekel, Knut .
BLOOD, 2007, 110 (08) :3078-3081
[6]   The proinflammatory CD14+CD16+DR++ monocytes are a major source of TNF [J].
Belge, KU ;
Dayyani, F ;
Horelt, A ;
Siedlar, M ;
Frankenberger, M ;
Frankenberger, B ;
Espevik, T ;
Ziegler-Heitbrock, L .
JOURNAL OF IMMUNOLOGY, 2002, 168 (07) :3536-3542
[7]   Impact of type-I-interferon on monocyte subsets and their differentiation to dendritic cells - An in vivo and ex vivo study in multiple sclerosis patients treated with interferon-beta [J].
Bergh, FT ;
Dayyani, F ;
Ziegler-Heltbrock, L .
JOURNAL OF NEUROIMMUNOLOGY, 2004, 146 (1-2) :176-188
[8]   Human dendritic cell subset 4 (DC4) correlates to a subset of CD14dim/- CD16++ monocytes [J].
Calzetti, Federica ;
Tamassia, Nicola ;
Micheletti, Alessandra ;
Finotti, Giulia ;
Bianchetto-Aguilera, Francisco ;
Cassatella, Marco A. .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2018, 141 (06) :2276-2279
[9]   Heterogeneity in the Locomotory Behavior of Human Monocyte Subsets over Human Vascular Endothelium In Vitro [J].
Collison, Joanna L. ;
Carlin, Leo M. ;
Eichmann, Martin ;
Geissmann, Frederic ;
Peakman, Mark .
JOURNAL OF IMMUNOLOGY, 2015, 195 (03) :1162-1170
[10]   Placebo-Controlled Trial of Oral Laquinimod for Multiple Sclerosis [J].
Comi, Giancarlo ;
Jeffery, Douglas ;
Kappos, Ludwig ;
Montalban, Xavier ;
Boyko, Alexey ;
Rocca, Maria A. ;
Filippi, Massimo .
NEW ENGLAND JOURNAL OF MEDICINE, 2012, 366 (11) :1000-1009